» Articles » PMID: 33171788

Liver Cirrhosis in Chronic Hepatitis B Patients Is Associated with Genetic Variations in DNA Repair Pathway Genes

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Nov 11
PMID 33171788
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cirrhosis (LC), contributing to more than 1 million of deaths annually, is a major healthcare concern worldwide. Hepatitis B virus (HBV) is a major LC etiological factor, and 15% of patients with chronic HBV infection (CHB) develop LC within 5 years. Recently, novel host genetic determinants were shown to influence HBV lifecycle and CHB course. DNA repair enzymes can affect dynamics of liver damage and are involved in HBV covalently closed circular DNA (cccDNA) formation, an essential step for viral replication. This study aimed to evaluate the possible role of genes representing key DNA-repair pathways in HBV-induced liver damage. MALDI-TOF MS genotyping platform was applied to evaluate variations within , , , , , , and genes. Apart from older age ( < 0.001), female sex ( = 0.021), portal hypertension ( < 0.001), thrombocytopenia ( < 0.001), high HBV DNA ( = 0.001), and high aspartate aminotransferase (AST) ( < 0.001), we found that G allele at rs238406 (, = 0.025), T allele at rs25487 (, = 0.012), rs13181 GG genotype (, = 0.034), and C allele at rs2735383 (, = 0.042) were also LC risk factors. The multivariate logistic regression model showed that rs25487 CC ( = 0.005) and rs238406 TT ( = 0.027) were independently associated with lower risk of LC. This study provides evidence for the impact of functional and potentially functional variations in key DNA-repair genes and in HBV-induced liver damage in a Caucasian population.

Citing Articles

Exploring Hepatocellular Carcinoma Pathogenesis: The Influence of Genetic Polymorphisms.

Mollazadeh S, Saeedi N, Al-Asady A, Ghorbani E, Khazaei M, Ryzhikov M Curr Pharm Des. 2024; 31(6):432-442.

PMID: 39297458 DOI: 10.2174/0113816128327773240827062719.


Liver Cirrhosis of Unknown Etiology and Its Predictors in Eastern Ethiopia.

Mekuria A, Nedi T, Gong Y, Abula T, Engidawork E Risk Manag Healthc Policy. 2024; 17:225-232.

PMID: 38282786 PMC: 10812135. DOI: 10.2147/RMHP.S425954.


Contribution of Aflatoxin B Exposure to Liver Cirrhosis in Eastern Ethiopia: A Case-Control Study.

Mekuria A, Xia L, Ahmed T, Bishaw S, Teklemariam Z, Nedi T Int J Gen Med. 2023; 16:3543-3553.

PMID: 37605782 PMC: 10440104. DOI: 10.2147/IJGM.S425992.


Interleukin-16 genetic polymorphisms in Guangxi Chinese with hepatitis B virus-related liver cirrhosis.

Zhang X, Tang W, Qin X, Li S, Liang D Mol Biol Rep. 2023; 50(6):5247-5254.

PMID: 37138138 DOI: 10.1007/s11033-023-08450-0.


Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma.

Horackova K, Frankova S, Zemankova P, Nehasil P, cerna M, Neroldova M Cancers (Basel). 2023; 15(1).

PMID: 36612198 PMC: 9818325. DOI: 10.3390/cancers15010201.


References
1.
Isakova J, Talaibekova E, Aldasheva N, Vinnikov D, Aldashev A . The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females. BMC Cancer. 2017; 17(1):758. PMC: 5683588. DOI: 10.1186/s12885-017-3762-y. View

2.
Luo J, Luckenbaugh L, Hu H, Yan Z, Gao L, Hu J . Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation. mBio. 2020; 11(1). PMC: 7029148. DOI: 10.1128/mBio.03423-19. View

3.
Hollingworth R, Skalka G, Stewart G, Hislop A, Blackbourn D, Grand R . Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. Viruses. 2015; 7(6):2908-27. PMC: 4488719. DOI: 10.3390/v7062752. View

4.
Tasnim T, Al-Mamun M, Nahid N, Islam M, Apu M, Bushra M . Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population. Tumour Biol. 2017; 39(11):1010428317729270. DOI: 10.1177/1010428317729270. View

5.
Dai P, Li J, Li W, Qin X, Wu X, Di W . Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(32):e16541. PMC: 6708677. DOI: 10.1097/MD.0000000000016541. View